There is a need for further refinement of current histological systems for assessment of hepatic fibrosis in nonalcoholic fatty liver disease (NAFLD). This study evaluated hepatic fibrosis in NAFLD using dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FPs). Fifty test cohort subjects and 42 validation cohort subjects with NAFLD and the full spectrum of fibrosis were studied. q-FPs were measured in specific predefined regions of interest (general, vessel, perisinusoid, and vascular septa). Seventy q-FPs had inter-and intraobserver concordance 0.8 and were related to the NASH Clinical Research Network fibrosis staging. Of these, 16 q-FPs with the strongest correlations (P < 0.001 for all) were entered in a principal component analysis model (odds ratio [OR] 7.8, P < 0.001), which separated any stage of fibrosis versus no fibrosis, and cirrhosis versus earlier stages with the areas under the receiver operating characteristic curves of 0.88 and 0.93 (P £ 0.01 for both), respectively. In an independent multivariable analysis, four q-FPs-the number of collagen strands (OR 8.5, P 5 0.004), strand length (OR 12.0, P 5 0.02), strand eccentricity (OR 8.3, P 5 0.004), and strand solidity (OR 8.0, P 5 0.003)-were independently associated with fibrosis stages and were used to model fibrosis along a continuous linear scale using desirability functions; this linear scale of fibrosis measurement was also related to fibrosis stage (P < 0.0001). The robustness of both the multivariable model and the linear scale of measurement was confirmed in the validation cohort. Conclusion: The q-FP model provides an accurate reproducible method to evaluate fibrosis in NAFLD along a quantitative and continuous scale. (HEPATOLOGY 2017;65:1891-1903.
N onalcoholic fatty liver disease (NAFLD) is a major cause of liver-related morbidity and mortality and is expected to surpass hepatitis C virus as an etiology for end-stage liver disease requiring liver transplantation.
(1) NAFLD may manifest as nonalcoholic fatty liver or nonalcoholic steatohepatitis (NASH). NASH progresses to cirrhosis more commonly than nonalcoholic fatty liver and is therefore the primary target for therapeutic development. (2) A principal objective in drug development for NASH is the prevention of progression to cirrhosis. (3) Although the architectural remodeling of the liver during progression to cirrhosis includes many components, the fibrosis stage is a robust readout of such progression and is used for histological assessment of disease progression. (4, 5) The National Institute of Diabetes and Digestive and Kidney Diseases NASH Clinical Research Network (CRN) system is the most widely used system of fibrosis assessment and classifies the disease into four stages as follows: (1a-c) based on acinar zone 3 perisinusoidal (1a, 1b) or portal/periportal distribution (1c); (2) zone 3 plus portal/periportal fibrosis; (3) as above, with bridging fibrosis; and (4) cirrhosis. (6) Although histological assessment of NASH has multiple strengths, (7) it also has some limitations, such as sampling error related to biopsy length and intra-and interobserver variability in assessment. (8) Furthermore, such systems convert the continuous range of fibrosis into an ordinal system introducing potential for error at the interface of different stages. The limited dynamic scale of measurement of current staging systems further hinders the ability to identify modest changes in fibrosis.
There are also logistical challenges with using histology-based assessment of NAFLD in community clinical practice. This has fueled efforts to identify all aspects of the disease noninvasively. Several circulating and imaging-based fibrosis markers are currently in development along with kinetic markers of fibrogenesis. (9) (10) (11) (12) (13) The current development path for such noninvasive methods are based on traditional histological assessment as the gold standard. From a methodological point of view, it is not possible to outperform the gold standard, and such developments are anchored with the "limitations" of the histological gold standards. There is therefore a need for further refinements in the histological assessment of NASH and hepatic fibrosis.
Recently, dual-photon microscopy has been used for assessment of hepatic fibrosis. (14, 15) This method identifies individual collagen fibrils in unstained paraffinembedded tissue sections and quantifies their physical attributes-such as number, length, diameter, orientation, contour, and cross-linkage with each other-within the context of hepatic architecture. It is thus technically quite different from other quantitative methods, such as collagen morphometry, which measures the area stained by collagen-specific stains (e.g., Sirius Red) and reads it out as a function of the total area measured (collagen proportional area). (16) Proofof-concept studies have demonstrated that dualphoton microscopy-based quantifiable fibrosis-related parameters (q-FPs) can be used to evaluate fibrosis in a rat model of fibrosis and in chronic hepatitis B. (14) However, it has not been evaluated for NASH, which is dominated by perisinusoidal fibrosis and formation of central-portal and central-central vein bridges, and thus is quite different than the mainly portal pattern of fibrosis seen with chronic viral hepatitis. (17) The overall objective of this study was to perform a proof-of-concept study to evaluate and validate the ability of q-FP-based analysis to quantitatively assess the hepatic fibrosis in NASH. The specific aims were to: (1) describe the spectrum of q-FPs that could be assessed in liver biopsies from humans with varying stages of NAFLD, (2) quantitate each measured q-FP and evaluate the test-retest repeat variability of the measures, (3) relate the distribution of the q-FPs to various fibrosis stages and develop a numerical fibrosis scoring system with an expanded dynamic scale of measurement, and (4) validate the model in an independent set of biopsies.
Subjects and Methods
This study was part of a larger human study of the natural history of disease progression and regression performed at Virginia Commonwealth University (VCU IRB 1960). All subjects provided informed consent to participate in the study. Deidentified slides were provided to collaborating investigators at Southern Medical University Nanfang Hospital who performed the dual-photon microscopy-based q-FP analysis. The q-FP analysis was then related to traditional histopathological analysis performed independently at Virginia Commonwealth University. Investigators at both centers participated in data analysis and interpretation. The authors designed, performed and analyzed the data and take full responsibility for the contents of the manuscript which has been written entirely by the authors.
STUDY POPULATION
The study population included subjects with varying phenotypes of NAFLD and controls with normal liver histology as assessed by two established liver pathologists (M.J.C. and M.O.I.). Liver tissue sections were taken from tissue blocks obtained at the time of a clinically indicated liver biopsy. Clinical and laboratory data matching the time of the liver biopsy were extracted from individual subject electronic medical records. Control individuals for this study were identified from those who had a liver biopsy for suspected NAFLD but were found to have <5% steatosis and no other histological lesions including fibrosis on routine evaluation of the biopsy. Subjects with alternate causes of liver disease such as hepatitis C, hepatitis B, hemochromatosis, and so forth were excluded. All subjects were considered to consume <30 g of alcohol daily for men and 20 g of alcohol daily for women based on clinical assessment as reported previously. (18, 19) ASSESSMENT OF ROUTINE LIVER HISTOLOGY NAFLD was defined by the presence of 5% macrovesicular steatosis. Steatohepatitis was defined using NASH CRN criteria. (6) All cases of steatohepatitis had steatosis, inflammation, and hepatocellular ballooning. Fibrosis was also staged according to the NASH CRN criteria from stages 0 to 4. For the purposes of this analysis, subjects with definite versus borderline steatohepatitis were considered together, and the substages of stage 1 were all considered as a single stage (stage 1), the rationale being that there is currently no evidence that the subclassifications of stage 1 are linked to clinically meaningful outcomes.
DUAL-PHOTON MICROSCOPY MEASUREMENT OF q-FPs
A paraffin-embedded section (4 lm thick) of each sample without any specific staining was prepared for dual-photon microscopy. Dual-photon microscopy imaging and processing by imaging software was performed as described previously. (14) Briefly, the whole section of each slice was imaged with a 203 objective and 512 3 512 pixels of resolution, and then the images of all slices were assessed with computerized image-analysis by two independent investigators (J.Y. and X.L.) to output the profile of q-FPs data for each slice. The q-FPs that were measured and applied for further analysis are listed in Supporting Table S1 . These q-FPs included fibrosis-related parameters such as collagen content, the geometric and textural features of collagen fibers, and the number of cross-linked collagen fibers. The image analysis software was programmed to measure collagen fibril characteristics in operator-defined segmentation regions of the liver tissue section as described previously (and as described in Supporting Table S1 ). (14) These included (1) general: the liver section in its entirety; (2) perisinusoidal: hepatocyteassociated collagen in the perisinusoidal space, (3) vessel: collagen fibrils directly connected to veins; and (4) vessel bridges: collagen fibrils extending from vein to vein or from vein to portal tract. Perisinusoidal fibrosis was defined as the fibrosis signal that is adjacent to hepatocytes in the parenchyma and excluded the signal associated with vessels or septa extending from vessels. The image analysis software is currently unable to distinguish definitely between central veins and portal veins, and vessel-associated collagen was not dependent on the type of vessel. There are thus technical distinctions between q-FP analyses of collagen versus traditional histological methods. Interested readers are referred to previous publications on more technical details of measurement. (14, 15) APPROACH TO VALIDATE q-FP BASED ASSESSMENT OF FIBROSIS IN NAFLD
Reproducibility of the Measurements
Each biopsy was evaluated by two different investigators each on two different days. The concordance data were then computed to determine the intra-and interobserver agreement for each q-FP. Only q-FPs with an intraclass correlation coefficient (ICC) 0.8 were used for further analysis.
Defining the Spectrum of Changes in q-FPs Across the Fibrosis Spectrum of NAFLD
The distribution of q-FP scores across the full spectrum of NAFLD-related fibrosis was measured in the test cohort. The mean value for each q-FP was normalized to a value between 0 and 1 by relating it to the total score for that q-FP across all stages. The normalized mean scores were visualized in a heat map to compare the general distribution of changes across different stages of disease and different regions (general, perisinusoidal, vessel, and vessel bridges) of the liver sections. The change in q-FP scores between adjacent stages, as defined by (q-FP n11 -q-FP n )/q-FP n , was used to further visualize those that changed progressively with increasing disease stage. This was performed for general, vascular, perisinusoidal regions, and vascular bridges separately.
Concordance With Traditional Histological Assessment
Spearman's correlation coefficients were determined to relate each q-FP to traditional fibrosis stage in the test cohort. Of those that were significantly related, a subset in which the q-FPs were not correlated with each other in terms of their operational definitions were selected to avoid colinearity and entered into a multivariable ordinal logistic regression analysis to develop a model of q-FP evolution in NASH. The area under the receiver operating characteristic curve (AUROC) for the overall model was then computed. In an alternate analysis, a model was developed from a principal component analysis (PCA) of q-FPs that were significantly correlated with fibrosis stage on univariable analysis. The AUROCs were also tested in an independent set of biopsies (validation cohort) and related to the NASH CRN histological stage to confirm the robustness of the model.
Extending the Dynamic Scale of Measurement by a Linearized Scale of Assessment
Validation of q-FP scores against traditional fibrosis stages does not obviate the limitations of traditional staging, especially with respect to an expanded dynamic range with a continuous scale. This was accomplished by application of the desirability functions using methodology similar to that described by us before. (20) Desirability functions can reset and transform the range of scores so that the lower end reflects a biologically desirable state and is given a score of 0, while the upper end reflects a very undesirable state and given a score of 1. Thus for NASH, a score of 0 would be reflective of absence of fibrosis, whereas a score of 1 would reflect the presence of cirrhosis. The best discriminant score separating stages 0 and 1 based on the regression analysis described above was set as 0. Conversely, the score discriminating stage 3 versus stage 4 was set as 1. All individual scores below the threshold for 0 were scored as 0, whereas all scores above the threshold for 1 were scored as 1.
Scores for 4 q-FP parameters found to be significantly related to conventional fibrosis stages from the multivariable regression model described above were converted to a desirability function between 0 and 1. These individual desirability functions were then combined using the geometric mean to arrive at a composite measure of the overall index, such as
This thus provided a composite desirability index with an infinite scale for measurement of dynamic changes in fibrosis. Interested readers are also referred to detailed reviews of this methodology for the mathematical background and validity of this approach. (20, 21) 
SAMPLE SIZE AND STATISTICAL ANALYSIS
Sample size assessment was done with NQuery (version 4.0). Based on a correlation coefficient of 0.8 or higher and setting the P value at 0.05 with two-sided testing along with a ratio of samples in the gold standard versus new method of 1, a sample size of 40 would provide approximately 100% power. Because we were unsure of the correlation when we started, a sample size of 50 was used for the model building cohort.
Standard descriptive statistics were used to describe the populations and quantify q-FPs. The choice of statistical tests used to compare groups was based on the type of measure and its distribution. Intra-and interobserver agreement was evaluated by ICC analysis. ICC was also used for identifying the concordance between q-FP measures of the virtually decreased sample length (i.e., 10 mm and 5 mm, respectively) versus the original length of biopsies. Spearman rank correlation coefficient was used for correlations between variables. Multivariable analysis following univariable logistic regression was used to test the q-FPs independently associated with categorical variables. PCA was performed and provided the variables for the PCAbased model. Two-sided P values < 0.05 were considered significant.
Results
Liver biopsy slides from 50 subjects were used as the test cohort. The demographic, clinical, and general histological findings from these subjects are shown in Table  1 . The subjects were largely overweight or obese and insulin-resistant. Individuals with a fatty liver did not have any fibrosis (stage 0). Of those with steatohepatitis, the fibrosis stages were more or less equally distributed from stage 0 to stage 4 (cirrhosis). Thus, the entire spectrum of fibrosis associated with NASH was present in the cohort. A second set of 42 biopsies from an independent group of subjects were used to validate the model. They broadly resembled the test cohort with respect to demographic, clinical, and histological findings.
REPRODUCIBILITY OF THE MEASUREMENTS AND OBSERVER VARIABILITY
The q-FP parameters noted in Supporting Table S1 were measured as described previously. (14) To evaluate the test-retest variability in these measures, the intraand interobserver concordances for the measures were analyzed from 10 randomly selected liver biopsy samples encompassing all stages of fibrosis. In ICC analysis, average inter-and intraobserver concordances were 0.87 6 0.30 and 0.87 6 0.29, respectively. We then set a criterion of ICC 0.80 for selecting the q-FP to be used for further model development. A total of 70 q-FPs were qualified, with the final average inter-and intraobserver agreement of 0.97 6 0.03 and 0.98 6 0.03, respectively (Supporting Table S2 ).
To further evaluate the impact of biopsy length on the assessment of q-FPs, virtual sections of individual biopsies with decreasing size were assessed in comparison with the ones of their original size. Data for the 70 q-FPs remained concordant (ICC 0.95 6 0.03) even when the length of virtual sections decreased to 10 mm from 21 mm (12-72 mm). When the length decreased to 5 mm, the concordance dropped to 0.83 6 0.22.
THE SPECTRUM OF q-FPs ACROSS THE RANGE OF FIBROSIS IN NAFLD
The overall amount and pattern of collagen visualized by dual-photon microscopy was similar to that identified by traditional histological staging of fibrosis (Fig. 1) . The normalized mean values for the 70 q-FPs selected are shown in Figure 2 . The parameters overlapped between stages 1 and 2, likely reflecting the presence of perisinusoidal fibrosis in both stage 1 (perisinusoidal or periportal fibrosis) and stage 2 (periportal and perisinusoidal fibrosis). (6) Visually, there was a distinct separation with advancing fibrosis stages. The q-FP measures were not significantly different from stage Data are presented as n (%) or median (range). Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index.
1a to 1b and 1c, although there tended to be higher q-FP values associated with vessels in stage 1c (Supporting Fig. S1 ). At the other end of the fibrosis spectrum, some differences in the zonation-based subtypes of stage 4 fibrosis were evident with higher collagen fibril content, number, length, thickness, and cross-link numbers at the vessel region in zone 1 versus zone 3 dominant cirrhosis (P 5 0.02-0.04) (Supporting Fig. S2 ).
SPECIFIC CHANGES IN q-FPs WITH STAGE TRANSITIONS
Next, the changes in q-FPs, defined as (q-FP n11 2 q-FP n )/q-FP n , between the adjacent fibrosis stages were evaluated (Fig. 3) . From stages 0 to 1, there was an increase in the levels of q-FPs in the general and vessel regions; three (4.3%) q-FPs had a significant increase (P < 0.05 for all), mainly including the q-FPs of collagen fibril number in vessel region. From stages 1 to 2, the increase was still mainly in the q-FPs in the general section and vessel region; three (4.3%) of the total number of q-FPs mainly related to perisinusoidal collagen fibrils were also increased significantly (P < 0.05 for all). Although some septal parameters changed, this did not reach significance. A total of 44 (62.8%) q-FPs changed significantly (P < 0.05 for all) with progression to stage 3; these included all geometric texture features of collagen fibrils in the vessel bridges and sinusoidal regions and the number and texture features in the general section. Progression to cirrhosis was associated with further changes in 25 (35.7%) remaining q-FPs (P < 0.05 for all). Overall, 47 (67.1%) q-FPs had a 1.8-fold (1.1-3.2) increase (P < 0.01 for all) from stages 1 to 4.
CONCORDANCE WITH TRADITIONAL HISTOLOGICAL ASSESSMENT
Fifty-three (75.7%) of the 70 q-FPs analyzed were significantly correlated with conventional fibrosis stages (P < 0.01 for all, c s 5 0.75-0.35) (Supporting Table S3 ). Among these, 16 q-FPs (22.8%) with the strongest correlation to fibrosis stage (c s 0.70, P < 0.001 for all) were selected for the univariable logistic regression analysis (Supporting Table S4 ). Notably, q-FP of collagen content did not reach the correlation standard (c s 0.70) and thus was not included in the 16 q-FPs, indicating its inadequacy for reflecting the full range of fibrosis progression as documented. (22) In the first model, a PCA index was developed using the 16 q-FPs with strongest correlation to fibrosis stage. Regression analysis of PCA index indicated its ability to significantly predict fibrosis stages (odds ratio [OR], 7.8; 95% confidence interval, 3.4-18.0; P < 0.001). It was also able to separate any stage of fibrosis from no fibrosis and cirrhosis from lower stages with AUROCs of 0.88 (P 5 0.01) and 0.93 (P < 0.001), respectively ( Table 2) .
Next, a multivariable ordinal logistic regression was performed using parameters significant on univariable analysis that were unrelated in terms of the physical property being measured. These identified four qFPs-the number of strands (OR 8.5, P 5 0.004), strand eccentricity (OR 8.3, P 5 0.004), strand solidity (OR 8.0, P 5 0.003) in the general section, and strand length (OR 12.0, P 5 0.02) in the vessel region-as the parameters that were independently related to fibrosis stage (Supporting Table S5 ). The distributions of these parameters with increasing stage are shown in Figure 4 and Supporting Table S6 .
The AUROCs ranged from 0.81 to 0.92 and were all significant for evaluating the ability of the four q-FPs to correctly identify various stages of fibrosis ( Table 2 ). The AUROCs for the minimal model were not significantly different from those of the PCA model described above.
EXTENDING THE DYNAMIC SCALE OF MEASUREMENT
The four q-FPs with significance on the multivariable regression analysis were used to develop desirability functions in which a score of 0 reflected the mean scores with a traditional fibrosis stage 0 (i.e., highly desirable), whereas the mean score for stage 4 was given a score of 1 (i.e., highly undesirable). The desirability scores as a function of parameter score are shown in Figure 5A -D. The overall q-FP desirability index demonstrated a linear relationship to traditional fibrosis stage (Fig. 5E ).
ASSESSMENT OF THE MULTIVARIABLE MODEL AND DESIRABILITY FUNCTIONS IN VALIDATION COHORT
In an independent set of liver biopsies (n 5 42) scored by an independent pathologist with no access to q-FP data, the q-FP scores were computed by the investigators. The ability of the four q-FPs to discriminate between fibrosis stages 0-4 was reconfirmed as shown in Figure 6 ; the corresponding AUROCs are summarized in Supporting Table S7 . The q-FP desirability index was also linearly and strongly correlated (P < 0.0001) with the traditional fibrosis stages in this set of biopsies (Fig.  5E) . Furthermore, the slopes of the regression lines for the test and validation cohorts were not significantly different (pooled slope 5 0.17/stage).
An additional set of four subjects who had two or three serial biopsies over a period of 4-8 years were also evaluated to probe the ability to tell the differences in fibrosis between biopsy pairs. The pairs were staged to be 3 versus 3, 1 versus 1 versus 1, 2 versus 3, and 3 versus 3, respectively. The four q-FPs all increased to a greater degree in the subject with an increase in fibrosis stage compared with those who maintained their fibrosis stage; meanwhile, they also detected fine differences in fibrosis even within the same stage for the individual pairs, suggesting that the q-FPs might be sensitive to read the serial changes (Supporting Fig. S3 ).
Discussion
The assessment of hepatic fibrosis, as a marker of disease progression or regression, has assumed center stage in the evaluation of NASH. (23) The current study represents an effort to use dual-photon-based assessment of hepatic fibrosis as a further refinement of traditional histological assessment. The ability to perform partially computerized assessment of q-FPs also carries the potential to bring some degree of automation to the process and thereby facilitate the overall assessment of liver histology by the pathologist. It is, however, important to note that histological assessment of NASH involves evaluation of all the other features of NASH, including disease activity, which require visual assessment by a pathologist.
An advantage of q-FP-based assessment of hepatic fibrosis is the robustness of its accuracy over a range of 
FIG. 5.
Desirability functions of number of strands (NoStr), strand eccentricity (StrEccentricity), strand solidity (StrSolidity) and strand length in vessel region (StrLengthV) and the combination of them. The mean values of the four fibrosis-related parameters (q-FPs) found to be significant based on logistic regression (described in results section) were plotted against the desirability function for the test cohort. The desirability function was set at 0 for stage 0 fibrosis, indicating a highly desirable state of fibrosis, whereas the desirability function for score at threshold of stages 3-4 was given a score of 1, indicating established cirrhosis and thus an undesirable state. The mean q-FP scores for stages 1-3 were given varying desirability scores based on the relative change in mortality risk, with incremental stage based on mortality risk per stage. (27) (A-D) The shape of the resultant plot was used to determine the relationship of the q-FP score to desirability function for the four parameters. (E) Overall q-FP desirability index (the geometric mean of the individual scores for individual subjects) and its relationship to traditional fibrosis staging. There was a tight linear relationship between the overall q-FP index and fibrosis stage for both the test and validation cohorts. The slopes of the data for the two cohorts were not significantly different.
liver biopsy lengths. One of the principal requirements for high-quality traditional histological assessment of the liver is the need for an adequate liver biopsy sample size. (24) Indeed, many current trials mandate a biopsy length of 2 cm or greater for subjects to be included. However, in clinical practice, the core size obtained is often smaller than this, and many published studies have reported smaller liver biopsy sizes limiting the reliability of the histologic reads. (18, 19) In this study, multiple smaller sections of the scanned tissue were evaluated, and the results were found to be remarkably reproducible. The q-FP method thus overcomes a potential barrier to more accurate assessment of fibrosis when the tissue sample obtained is less than 1.5-2 cm in length.
Another advantage of the q-FP methodology is that it provides a quantitative result along a continuous numerical scale using the desirability functions used in this study. Such functions have been used as quality assessment tools in industry and are now beginning to be evaluated in medical contexts. (21, 25) The extended dynamic range may allow assessment of more nuanced changes in fibrosis that may not be captured by traditional scales given their limited range Table S7 for further details regarding these data. of measurement. This may potentially allow faster detection of therapeutic benefit in clinical trials. Furthermore, measuring fibrosis along a continuous scale overcomes the errors inherent in assessment of fibrosis using ordinal cutoffs.
In an era of intense ongoing research to develop noninvasive assessment of disease status for NASH, some may question the need for refinement of existing histological methods of fibrosis assessment. It is worth noting that none of the noninvasive methods have met evidentiary standards of biomarker qualification allowing them to be approved specifically for assessment of hepatic fibrosis and that their development is tied to traditional histological assessment with its accompanying strengths and weaknesses. The refinement of the conventional histological assessment to overcome its current limitations will not only potentially benefit therapeutic development efforts but also benefit development of biomarkers by serving as a better gold standard.
In the future, based on this initial cross-sectional study, the q-FP score will require longitudinal validation against clinical outcomes to define its specific use. Furthermore, it may permit an alternate way to evaluate the range of fibrosis evolution especially from bridging fibrosis to cirrhosis. If short-term changes along an extended range of fibrosis assessment can be linked to reduced risk of cirrhosis development, such changes could be used as a surrogate endpoint to establish treatment benefit and shorten the time needed for drug development. This is of course hypothetical and a direction for future studies. Similarly, the findings of collagen directly related to vascular and biliary structures corroborate and extend prior findings (26) and provide further impetus to the assessment of central and portal veins as well as biliary epithelium in disease progression in NASH.
In conclusion, q-FP can be used as an objective, reliable measure of fibrosis stage along a numerical scale in subjects with NASH. Although more work needs to be done to validate and refine the model using much larger data sets, this study provides proof of concept for the feasibility of developing a quantitative numerical histological scale for assessment of fibrosis in NASH using dual-photon microscopy.
